pulmonologyadvisor9h
COVID-19 Vaccine: ACIP Recommends Added Doses in All With IC and Adults 65+
The CDC ACIP recommends 2 doses of the 2024-2025 COVID-19 vaccine for those age 65+ years and 2 or more doses for immunocompromised individuals.
pulmonologyadvisor9h
Interstitial Lung Disease May Be Reliably Identified via LUS in Asymptomatic RA
Lung ultrasound (LUS) may be an effective screening tool for interstitial lung disease in patients with asymptomatic rheumatoid arthritis.
pulmonologyadvisor9h
Many in Need of Substance Use Disorder Treatment Not Receiving It
A gap persists between the need for and receipt of substance use disorder treatment among United States individuals.
pulmonologyadvisor9h
Drinking Coffee in Morning More Strongly Linked to Lower Mortality Risk
Coffee drinking timing is associated with all-cause and cardiovascular disease-specific mortality risk, according to study findings.
pulmonologyadvisor9h
RSV Vaccine Labeling Updated With Guillain-Barré Syndrome Warning
The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...
pulmonologyadvisor9h
About 1 in 4 Older US Veterans Report Cardiovascular Disease Diagnosis
One in four older US veterans report being diagnosed with cardiovascular disease in their lifetime, according to study findings.
pulmonologyadvisor9h
FDA Drug Approval Decisions Expected in February 2025
The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.
pulmonologyadvisor9h
Extended Nirmatrelvir/Ritonavir Beneficial for Some With Long COVID
Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not all benefits persist.